» Articles » PMID: 22584713

Biochemical, Bone and Renal Patterns in Hyperparathyroidism Associated with Multiple Endocrine Neoplasia Type 1

Overview
Publisher Elsevier
Specialty General Medicine
Date 2012 May 16
PMID 22584713
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Primary hyperparathyroidism associated with multiple endocrine neoplasia type I (hyperparathyroidism/multiple endocrine neoplasia type 1) differs in many aspects from sporadic hyperparathyroidism, which is the most frequently occurring form of hyperparathyroidism. Bone mineral density has frequently been studied in sporadic hyperparathyroidism but it has very rarely been examined in cases of hyperparathyroidism/multiple endocrine neoplasia type 1. Cortical bone mineral density in hyperparathyroidism/multiple endocrine neoplasia type 1 cases has only recently been examined, and early, severe and frequent bone mineral losses have been documented at this site. Early bone mineral losses are highly prevalent in the trabecular bone of patients with hyperparathyroidism/multiple endocrine neoplasia type 1. In summary, bone mineral disease in multiple endocrine neoplasia type 1 related hyperparathyroidism is an early, frequent and severe disturbance, occurring in both the cortical and trabecular bones. In addition, renal complications secondary to sporadic hyperparathyroidism are often studied, but very little work has been done on this issue in hyperparathyroidism/multiple endocrine neoplasia type 1. It has been recently verified that early, frequent, and severe renal lesions occur in patients with hyperparathyroidism/multiple endocrine neoplasia type 1, which may lead to increased morbidity and mortality. In this article we review the few available studies on bone mineral and renal disturbances in the setting of hyperparathyroidism/multiple endocrine neoplasia type 1. We performed a meta-analysis of the available data on bone mineral and renal disease in cases of multiple endocrine neoplasia type 1-related hyperparathyroidism.

Citing Articles

Bone mineral density over ten years after primary parathyroidectomy in multiple endocrine neoplasia type 1.

Kuusela E, Kostiainen I, Ritvonen E, Ryhanen E, Schalin-Jantti C JBMR Plus. 2024; 8(12):ziae129.

PMID: 39575107 PMC: 11579653. DOI: 10.1093/jbmrpl/ziae129.


Analysis of Bone Phenotype Differences in MEN1-Related and Sporadic Primary Hyperparathyroidism Using 3D-DXA.

Eremkina A, Pylina S, Elfimova A, Gorbacheva A, Humbert L, Picazo M J Clin Med. 2024; 13(21).

PMID: 39518523 PMC: 11546830. DOI: 10.3390/jcm13216382.


Role of Nutrition in the Management of Patients with Multiple Endocrine Neoplasia Type 1.

Marinari M, Marini F, Giusti F, Brandi M Nutrients. 2024; 16(11).

PMID: 38892509 PMC: 11174418. DOI: 10.3390/nu16111576.


Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.

Marini F, Giusti F, Cioppi F, Maraghelli D, Cavalli T, Tonelli F Cells. 2021; 10(8).

PMID: 34440663 PMC: 8391385. DOI: 10.3390/cells10081895.


Multiple endocrine neoplasia type 1 in patients with gastroenteropancreatic neuroendocrine tumors: An opportunity for early diagnosis and appropriate management.

Brabo E, Barbosa Moraes A, Dos Santos Marijuan Cabezas B, Vieira Neto L Mol Clin Oncol. 2020; 13(3):4.

PMID: 32754318 PMC: 7391838. DOI: 10.3892/mco.2020.2074.


References
1.
Thakker R . Multiple endocrine neoplasia type 1 (MEN1). Best Pract Res Clin Endocrinol Metab. 2010; 24(3):355-70. DOI: 10.1016/j.beem.2010.07.003. View

2.
Bilezikian J, Khan A, Potts Jr J . Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009; 94(2):335-9. PMC: 3214274. DOI: 10.1210/jc.2008-1763. View

3.
Marx S, Simonds W, Agarwal S, Burns A, Weinstein L, Cochran C . Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res. 2002; 17 Suppl 2:N37-43. View

4.
Christopoulos C, Antoniou N, Thempeyioti A, Calender A, Economopoulos P . Familial multiple endocrine neoplasia type I: the urologist is first on the scene. BJU Int. 2005; 96(6):884-7. DOI: 10.1111/j.1464-410X.2005.05731.x. View

5.
Coutinho F, Lourenco Jr D, Toledo R, Montenegro F, Correia-Deur J, Toledo S . Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy. Clin Endocrinol (Oxf). 2009; 72(4):462-8. DOI: 10.1111/j.1365-2265.2009.03672.x. View